Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Gynecologic Oncology|February 1, 1988
Adriamycin and cisplatin in the treatment of stage III and IV epithelial ovarian carcinomaW E Shelley, J C Carmichael, L B Brown, et al.
Gynecologic Oncology|July 1, 1987
A predictive index of cure versus no cure in advanced ovarian carcinoma patients--replacement of second-look laparotomy as a diagnostic testJ A Carmichael, W E Shelley, L B Brown, et al.
Cancer Treatment Reports|March 1, 1987
Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatinJ L Pater, J A Carmichael, G V Krepart, et al.
Pediatric Blood & Cancer|August 11, 2015
Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative GroupsOdile Oberlin, Annie Rey, Kenneth L B Brown, et al.
Pediatric Blood & Cancer|September 1, 2010
Treatment results for patients with localized, completely resected (Group I) alveolar rhabdomyosarcoma on Intergroup Rhabdomyosarcoma Study Group (IRSG) protocols III and IV, 1984-1997: a report from the Children's Oncology GroupR Beverly Raney, James R Anderson, Kenneth L B Brown, et al.
Archives of Neurology|January 14, 2000
Donepezil therapy in clinical practice: a randomized crossover studyS M Greenberg, M K Tennis, L B Brown, et al.
Pediatric Blood & Cancer|May 6, 2008
Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor CommitteeJames S Meyer, Helen R Nadel, Neyssa Marina, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2019
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohortSigbjørn Smeland, Stefan S Bielack, Jeremy Whelan, et al.
The Lancet. Oncology|August 30, 2016
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trialNeyssa M Marina, Sigbjørn Smeland, Stefan S Bielack, et al.
Pageof 5